Ascendis Pharma A/S
ASND
Ранг среди акций
#1497
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Цена акции
$234.15
Рыночная капитализация
$14.61B
Изменение (1 день)
1.82%
Изменение (1 год)
14.10%
Страна
DK
Торговля Ascendis Pharma A/S (ASND)
Категория
Healthcare
Количество находящихся в обращении акций Ascendis Pharma A/S (ASND)
Количество акций в обращении на June 2026: 64.34M
Согласно последним финансовым отчетам и цене акций Ascendis Pharma A/S, текущее количество акций в обращении составляет 64.34M. На конец December 2024 у компании было 57.89M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Ascendis Pharma A/S (ASND) с 2012 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 64.34M | 6.17% |
| 2025 | 60.61M | 4.69% |
| 2024 | 57.89M | 2.85% |
| 2023 | 56.29M | 0.38% |
| 2022 | 56.07M | 2.37% |
| 2021 | 54.77M | 8.21% |
| 2020 | 50.62M | 8.84% |
| 2019 | 46.51M | 13.20% |
| 2018 | 41.09M | 22.18% |
| 2017 | 33.63M | 26.58% |
| 2016 | 26.56M | 12.16% |
| 2015 | 23.68M | 39.85% |
| 2014 | 16.94M | 56.78% |
| 2013 | 10.80M | 0.00% |
| 2012 | 10.80M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | 294.59% |
US
|
|
| 396.00M | 515.43% |
US
|
|
| 478.91M | 644.29% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -3.36% |
NL
|
